Savvy Updates 4/21/25: Dexcom 15-Day CGM Frequency of Failure, 39 States Push Legislation Against PBM-Pharmacy Ties, Beta Bionics iLet After 2 years, Walking & Heart Health, How Much Protein Do We Need, Vit. K Affects Brain Health, Huge Amounts of Diabetes-Related Waste, Abbott US Diabetes Sales Up 27%, Wearing Socks & Better Sleep
In this week’s issue of The Savvy Diabetic: Dexcom 15-Day CGM: 25% May Not Last for 15 Days 39 States Push Legislation Against PBM-Pharmacy Ties to Protect Competition Beta Bionics iLet After 2 years, with Stacey Simms Take a Brisk Walk for Heart Health...
Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels
In this week’s issue of The Savvy Diabetic: Diabetes Research Institute (DRI) “Aggressively Working” on T1D Cure Microbiome Therapy To Delay T1D Onset Fully Closed AID Systems Effective Without Meal Announcements 2025 Breakthroughs in Diabetes...
Savvy Updates 3/31/25: Dexcom’s FDA Warning Letter & Response, CGM MARD Wars, Looking for Glucose Patterns, Microdosing GLP-1 Drugs, GLP-1 Drugs & The Brain & Peripheral Artery Disease, Islet Therapy Eliminates Severe Hypos & Reduces HbA1c, Beta Bionics iLet Sales Surge, SiBionics ‘World’s Thinnest’ CGM, Vicentra BV’s Kaleido 2 Insulin Patch Pump, Phenolic Preservatives & Inflammations, States to Curb Use of AI for Prior Authorizations
In this week’s issue of The Savvy Diabetic: Dexcom’s FDA Warning Letter & Dexcom’s Response Claims No Wrongdoing CGM MARD Wars, with Values without Context Looking for Glucose Patterns – See Trends & Possible Adjustments...
Savvy Updates 3/24/25: Extension of Special Diabetes Program, Funding Cut to Diabetes Prevention Program (DPP), Sequel Partners & Abbott FreeStyle Libre 3 Plus, Afrezza Lowers A1C, ATTD 2025 on Dexcom 15-day Sensor &Tandem Control-IQ for T2D, Non-Invasive Glucose Monitoring Using Photoacoustic Sensing, Increase in CKD, Cell Therapies for T1D, KDIGO CKD Guidelines, Medtronic InPen Device Issue, Duodenal Mucosal Resurfacing for T1D, Neural Origins of Sugar Cravings
In this week’s issue of The Savvy Diabetic: Breakthrough T1D Gratitude for Extension of Special Diabetes Program Funding Cut to Diabetes Prevention Program (DPP) Sequel Partners Integrates with Abbott FreeStyle Libre 3 Plus with Twiist Pump Afrezza Lowers...
Savvy Updates, 3/10/25: Dexcom’s FTC Warning Letter over Deficiencies, Double Diabetes, Mounjaro vs. Ozempic, Sleep & Glycemic Variability, Pathways to T1D Pharma Therapies, diaTribe Kidney /Heart /Metabolism Webinar, Smartphones & Brain Activity Impact, Hibiscus Health “Selfies” Detect D, FTC on PBMs System of “Disgusting” Higher Prices
In this week’s issue of The Savvy Diabetic: Dexcom’s FTC Warning Letter over Deficiencies Double Diabetes: Silent Threat Hiding in Type 1 Patients Mounjaro vs. Ozempic: Which One Is Right for You? Sleep Duration & Timing and Impact on...
More Diabetes Blogs